120 related articles for article (PubMed ID: 38036821)
1. Quantification of Clofarabine and Fludarabine in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
Schofield RC; Scordo M; Shah G; Carlow DC
Methods Mol Biol; 2024; 2737():175-184. PubMed ID: 38036821
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Determination of Prednisone and Prednisolone in Serum by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry.
Schofield RC; Scordo M; Shah G; Carlow DC
Methods Mol Biol; 2024; 2737():413-422. PubMed ID: 38036842
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS.
Huang L; Lizak P; Dvorak CC; Aweeka F; Long-Boyle J
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():194-9. PubMed ID: 24820973
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning.
Punt AM; Langenhorst JB; Egas AC; Boelens JJ; van Kesteren C; van Maarseveen EM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():81-85. PubMed ID: 28445850
[TBL] [Abstract][Full Text] [Related]
5. Determination of Treosulfan and Fludarabine in Plasma by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry (TFLC-MS/MS).
Hutcherson SM; Schofield RC; Carlow DC
Methods Mol Biol; 2024; 2737():453-463. PubMed ID: 38036846
[TBL] [Abstract][Full Text] [Related]
6. Measurement of ThioTEPA and Its Metabolite TEPA in Plasma and Cerebrospinal Fluid by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
Schofield RC; Scordo M; Shah G; Carlow DC
Methods Mol Biol; 2024; 2737():423-433. PubMed ID: 38036843
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry.
Veeraraghavan S; Thappali S; Viswanadha S; Nalla S; Chennupati S; Golla M; Vakkalanka S; Rangasamy M
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 949-950():63-9. PubMed ID: 24463402
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.
Wang H; Jones AK; Dvorak CC; Huang L; Orchard P; Ivaturi V; Long-Boyle J
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1603-1610. PubMed ID: 31002993
[TBL] [Abstract][Full Text] [Related]
9. Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS/MS.
Huang L; Lizak P; Aweeka F; Long-Boyle J
J Pharm Biomed Anal; 2013 Dec; 86():198-203. PubMed ID: 24013121
[TBL] [Abstract][Full Text] [Related]
10. Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells.
Puy JY; Jordheim LP; Cros-Perrial E; Dumontet C; Peyrottes S; Lefebvre-Tournier I
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1053():101-110. PubMed ID: 28415014
[TBL] [Abstract][Full Text] [Related]
11. Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
Schofield RC; Scordo M; Shah G; Carlow DC
Methods Mol Biol; 2024; 2737():141-151. PubMed ID: 38036818
[TBL] [Abstract][Full Text] [Related]
12. Rational Alternatives to Fludarabine and Cyclophosphamide-Based Pre-CAR Lymphodepleting Regimens in the Pediatric and Young Adult B-ALL Setting.
Green S; Schultz L
Curr Oncol Rep; 2023 Aug; 25(8):841-846. PubMed ID: 37099243
[TBL] [Abstract][Full Text] [Related]
13. Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes.
Alatrash G; Saberian C; Bassett R; Thall PF; Ledesma C; Lu Y; Daher M; Valdez BC; Kawedia J; Popat U; Mehta R; Oran B; Nieto Y; Olson A; Anderlini P; Marin D; Hosing C; Alousi AM; Shpall EJ; Rondon G; Chen J; Qazilbash M; Champlin RE; Kebriaei P
Transplant Cell Ther; 2022 Aug; 28(8):501.e1-501.e7. PubMed ID: 35618218
[TBL] [Abstract][Full Text] [Related]
14. Improved quantitative method for fludarabine in human plasma by liquid chromatography and tandem mass spectrometry.
Ng ES; Kangarloo SB; Daly A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():103-10. PubMed ID: 23777614
[TBL] [Abstract][Full Text] [Related]
15. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946
[TBL] [Abstract][Full Text] [Related]
16. Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Andersson BS; Valdez BC; de Lima M; Wang X; Thall PF; Worth LL; Popat U; Madden T; Hosing C; Alousi A; Rondon G; Kebriaei P; Shpall EJ; Jones RB; Champlin RE
Biol Blood Marrow Transplant; 2011 Jun; 17(6):893-900. PubMed ID: 20946966
[TBL] [Abstract][Full Text] [Related]
17. A sensitive LC-MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells.
Tu X; Lu Y; Zhong D; Zhang Y; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():202-7. PubMed ID: 24529342
[TBL] [Abstract][Full Text] [Related]
18. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Fabrizio VA; Boelens JJ; Mauguen A; Baggott C; Prabhu S; Egeler E; Mavroukakis S; Pacenta H; Phillips CL; Rossoff J; Stefanski HE; Talano JA; Moskop A; Margossian SP; Verneris MR; Myers GD; Karras NA; Brown PA; Qayed M; Hermiston M; Satwani P; Krupski C; Keating AK; Wilcox R; Rabik CA; Chinnabhandar V; Kunicki M; Goksenin AY; Mackall CL; Laetsch TW; Schultz LM; Curran KJ
Blood Adv; 2022 Apr; 6(7):1961-1968. PubMed ID: 34788386
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
Alatrash G; Thall PF; Valdez BC; Fox PS; Ning J; Garber HR; Janbey S; Worth LL; Popat U; Hosing C; Alousi AM; Kebriaei P; Shpall EJ; Jones RB; de Lima M; Rondon G; Chen J; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1792-1800. PubMed ID: 27377901
[TBL] [Abstract][Full Text] [Related]
20. Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
Molteni A; Riva M; Ravano E; Marbello L; Mancini V; Grillo G; Zucchetti E; Greco R; Cairoli R
Int J Hematol; 2017 Jun; 105(6):769-776. PubMed ID: 28220349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
